These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1829910)

  • 21. Abbott monoclonal enzyme immunoassay measurement of estrogen receptors in human breast cancer: a European multicenter study.
    Leclercq G; Bojar H; Goussard J; Nicholson RI; Pichon MF; Piffanelli A; Pousette A; Thorpe S; Lonsdorfer M
    Cancer Res; 1986 Aug; 46(8 Suppl):4233s-4236s. PubMed ID: 2425942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Steroid receptor distribution in 47,892 breast cancers. A collaborative study of 7 European laboratories. The EORTC Receptor Study Group.
    Romain S; Lainé Bidron C; Martin PM; Magdelenat H
    Eur J Cancer; 1995; 31A(3):411-7. PubMed ID: 7786610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An enzyme immunoassay compared with a ligand-binding assay for measuring progesterone receptors in cytosols from breast cancers.
    Smyth CM; Benn DE; Reeve TS
    Clin Chem; 1988 Jun; 34(6):1116-8. PubMed ID: 3288376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioligand-labeled binding assay and immunochemical assay for estrogen receptor in 115 human breast cancers.
    Riccobon A; Zoli W; Capucci A; Volpi A; Vasini M; Bonaguri C; Flamini E; Ravaioli A; Amadori D
    Tumori; 1988 Apr; 74(2):167-70. PubMed ID: 3285555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of enzyme immunoassay and dextran-coated charcoal techniques for progesterone receptor determination in human breast cancer cytosols.
    Foekens JA; Portengen H; van Driel J; van Putten WL; Haije WG; Klijn JG
    J Steroid Biochem; 1988 Jun; 29(6):571-4. PubMed ID: 3290577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Determination of estrogen receptors in 160 breast tumors using monoclonal antibodies: comparison of Abbott's immunoenzymatic method with the carbon dextran method].
    Goussard J; Lechevrel C; Martin PM; Roussel G
    Bull Cancer; 1985; 72(3):168-82. PubMed ID: 2416370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enzyme immunoassay of estrogen receptors in fine needle aspirates of breast tumors.
    Magdelenat H; Merle S; Zajdela A
    Cancer Res; 1986 Aug; 46(8 Suppl):4265s-4267s. PubMed ID: 3524807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative monoclonal antibody determination of estrogen and progesterone receptors in human breast cancer: correlation with the radioligand method.
    Jarque F; Lluch A; Vizcarra E; Muñoz M; Alberola V; Garciá-Conde J
    Oncology; 1994; 51(5):435-9. PubMed ID: 8052485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative studies of estrogen receptor determinations by enzyme immuno-assay using the monoclonal antibody, dextran-coated charcoal, and sucrose density gradient methods].
    Tominaga T; Yoshida Y; Kitamura M; Kosaki G
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1782-6. PubMed ID: 2412495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
    Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG
    Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study of radioligand (DCC) and modified immunoperoxidase anti-estrogen receptor techniques in breast carcinoma.
    Kerner H; Zilberman M; Israeli E; Lichtig C
    Isr J Med Sci; 1994 Jul; 30(7):506-9. PubMed ID: 7519589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of estrogen receptors in human breast cancer: comparison between enzyme immunoassay and dextran-coated charcoal method.
    Bozzetti C; Naldi N; Guazzi A; Nizzoli R; Benecchi M; Cocconi G
    Tumori; 1986 Oct; 72(5):511-4. PubMed ID: 2432712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of an enzyme immunoassay for estrogen receptors in human breast cancers.
    Nicholson RI; Colin P; Francis AB; Keshra R; Finlay P; Williams M; Elston CW; Blamey RW; Griffiths K
    Cancer Res; 1986 Aug; 46(8 Suppl):4299s-4302s. PubMed ID: 3524811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of the 8S complex in oestrogen receptor recognition.
    Marsigliante S; Puddefoot JR; Barker S; Goode AW; Vinson GP
    J Steroid Biochem Mol Biol; 1991 Nov; 39(5A):703-11. PubMed ID: 1958507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discrepancies between antibody (EIA) and saturation analysis of oestrogen receptor content in breast tumour samples.
    Marsigliante S; Puddefoot JR; Barker S; Gledhill J; Vinson GP
    J Steroid Biochem Mol Biol; 1990 Dec; 37(5):643-8. PubMed ID: 2278849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a new oestrogen receptor assay.
    Alexander AI; Mercer RJ; Lie TH; Letchford D; Bennett RC
    Aust N Z J Surg; 1986 Aug; 56(8):651-5. PubMed ID: 3530230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microtiter plate immunoenzymometric assay for estrogen receptor.
    Delage V; Teulon JM; Bellanger L; Seguin P; Descotes F; Saez S
    Clin Chem; 1996 Dec; 42(12):1955-60. PubMed ID: 8969632
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of estrogen receptor in breast cancer using monoclonal antibody technology: results of a multicenter study in the United States.
    Jordan VC; Jacobson HI; Keenan EJ
    Cancer Res; 1986 Aug; 46(8 Suppl):4237s-4240s. PubMed ID: 3524804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hormone receptor determination in breast cancer using the dextran- coated charcoal method and monoclonal antibodies: correlation with cytomorphologic grading].
    Schenck U; Jütting U; Eiermann W
    Onkologie; 1988 Oct; 11(5):211-5. PubMed ID: 3059248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison between single saturating dose ligand binding assay and enzyme immunoassay for low-salt extractable oestrogen and progesterone receptors in breast cancer: a multicentre study.
    Gion M; Dittadi R; Leon AE; Bruscagnin G; Pelizzola D; Giovannini G; Giganti M; Messeri G; Quercioli M; Flamini E
    Eur J Cancer; 1991; 27(8):996-1002. PubMed ID: 1832912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.